An artificial bone substitute used for structural bone replacement typically when bone is lost due to disease (e.g., osteoporosis) or injury. It consists mainly of porous and mesh ceramic materials that provide a framework for bone growth, or harvested sea cor
| Company | Devices | Share |
|---|---|---|
| Genoss Co., Ltd. | 133 | 15% |
| Biogennix, Llc | 99 | 11% |
| Inion Oy | 80 | 9% |
| Globus Medical, Inc. | 62 | 7% |
| Kasios | 50 | 6% |
| Orthogem Ltd | 42 | 5% |
| Bio2 Technologies, Inc. | 42 | 5% |
| Wiltrom Co., Ltd. | 41 | 5% |
| Wiltrom Co., Ltd. (Chutung) | 39 | 4% |
| Biocomposites Ltd | 29 | 3% |
| Noraker | 21 | 2% |
| Etex Corporation | 21 | 2% |
Company = labeler of record on GUDID. 43 companies in total; top 12 shown. Click headers to sort.
Sample of brand names as labelled; no endorsement. Ask us for the full list with company, model and UDI.
| Code | Name | Devices |
|---|---|---|
| MQV | Filler, Bone Void, Calcium Compound | 665 |
| LYC | Bone grafting material, synthetic | 155 |
| MQV | FILLER, BONE VOID, CALCIUM COMPOUND | 127 |
| LYC | Bone Grafting Material, Synthetic | 114 |
| OIS | Calcium Salt Bone Void Filler, Drillable, Non-Screw Augmenta | 43 |
| KNW | Instrument, Biopsy | 13 |
Use these as the dimensions to specify in a tender line.
871 device records in commercial distribution are listed on the FDA Global Unique Device Identification Database (GUDID) under the GMDN category "Synthetic bone graft", from 43 companies. The largest labeler is Genoss Co., Ltd. with 15% of records.
MQV (Filler, Bone Void, Calcium Compound), LYC (Bone grafting material, synthetic), MQV (FILLER, BONE VOID, CALCIUM COMPOUND), LYC (Bone Grafting Material, Synthetic)
No. GUDID is the US register. For the UAE (MOHAP/DoH) and Saudi (SFDA/MDMA) a separate registration and a local authorised representative are required; Consulting Wallah can check the status and connect you with registered suppliers.
Add synthetic bone graft to the RFQ basket or use the form below with quantity, specification and delivery location; the Network returns comparable quotes from verified suppliers in 2–5 working days.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Source: FDA AccessGUDID (AccessGUDID full release 2 Nov 2026); counts are device records in commercial distribution grouped by GMDN preferred term; companies are labelers of record. Information only — US listing is not a registration in the UAE or GCC; verify with the regulator. © Consulting Wallah — CC BY‑NC‑ND.